KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Diebold Nixdorf (DBD) EBT (2016 - 2025)

Diebold Nixdorf's EBT history spans 17 years, with the latest figure at $62.8 million for Q4 2025.

  • For Q4 2025, EBT rose 866.15% year-over-year to $62.8 million; the TTM value through Dec 2025 reached $125.0 million, up 164.27%, while the annual FY2025 figure was $125.1 million, 164.48% up from the prior year.
  • EBT reached $62.8 million in Q4 2025 per DBD's latest filing, up from $52.4 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $62.8 million in Q4 2025 to a low of -$701.5 million in Q2 2023.
  • Average EBT over 5 years is -$59.5 million, with a median of -$7.4 million recorded in 2025.
  • Peak YoY movement for EBT: plummeted 9676.92% in 2022, then skyrocketed 866.15% in 2025.
  • A 5-year view of EBT shows it stood at -$1.3 million in 2021, then tumbled by 9676.92% to -$127.1 million in 2022, then soared by 82.3% to -$22.5 million in 2023, then skyrocketed by 128.89% to $6.5 million in 2024, then surged by 866.15% to $62.8 million in 2025.
  • Per Business Quant, the three most recent readings for DBD's EBT are $62.8 million (Q4 2025), $52.4 million (Q3 2025), and $17.2 million (Q2 2025).